07 Jan 2001

Cefakliman® (Cefakliman® Tabletten) - Deutschland

Updated: 07 Jan 2001

Cefakliman®

Klimakterische Ausfallserscheinungen.

Cefakliman® Description, Presentation and Dosage

Cefakliman® Description

Cefakliman® Drug Class Description

Kombinationen

Cefakliman® Drug Description

1 Tbl. enth.: Lachesis D12 10 mg, Cimicifuga D5 10 mg, Sepia D5 10 mg, Lilium tigrinum D5 10 mg.

Cefakliman® Generic Name

Cefakliman® Tabletten

Cefakliman® Presentation

Cefakliman® Presentation

Cefakliman®

Cefakliman® Manufacturer

Cefak

Related Learning Zones

Anti-Coagulation Video Channel

Anti-Coagulation Video Channel

The Anticoagulation Video Channel is regularly updated with expert videos discussing how to prevent stroke and systemic embolism in non-valvular atrial fibrillation (AF) patients and how to prevent and treat venous thromboembolism (VTE). This free resource is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with AF or VTE.

This resource has been developed in collaboration with Boehringer Ingelheim.

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Cefakliman® Dosage

Cefakliman® Adult Dosage

Lactose, Magnesiumstearat.

Cefakliman® Precautions, Reactions and Contraindications

Cefakliman® Special Precautions

Related Drugs - Women's Health and Obs/Gyn

Back to top